News tagged ‘BasicResearch’ clear
- Researchers found a way of differentiating angiocentric gliomas from other low-grade pediatric brain tumors and developed a pathological test that will help children avoid unnecessary and potentially damaging additional therapies.
Tags: BasicResearch, ChildhoodCancer, BrainTumors
- Research by Dana-Farber scientists reveals genes with monoallelic expression are an important source of genetic diversity among people and also may help explain the genetic variation among cancer cells in a tumor.
Tags: BasicResearch, Genetics
- Dana-Farber researchers uncover first potential targeted drug for triple-negative breast cancer as well as vulnerability that could be exploited to slow or prevent the development of resistance to BET-inhibiting drugs.
Tags: BasicResearch, BreastCancer
- In a span of five weeks beginning in late October, the U.S. Food and Drug Administration (FDA) gave approval to five new cancer drugs that proved effective in Dana-Farber-led clinical trials – and, in some cases, derive from basic research in Dana-Farber laboratories.
Tags: chemotherapy, BasicResearch, LungCancer, MultipleMyeloma, Sarcoma
- The Commonwealth Foundation for Cancer Research has pledged $20 million to the Bridge Project, a collaborative research program of the Koch Institute for Integrative Cancer Research at MIT and Dana-Farber/Harvard Cancer Center, to accelerate the translation of interdisciplinary cancer solutions toward the clinic.
- Turning off a single gene leads to a roughly three-to-five-fold gain in the yield of laboratory methods for producing red blood cells from stem cells, according to new research published in Cell Stem Cell. The findings suggest a way to cost-effectively manufacture red blood cells from stem cells; the patients who could potentially benefit include those who cannot use blood currently available in blood banks.
Tags: BasicResearch, ChildhoodCancer, Genomics
- New research by Dana-Farber Cancer Institute scientists raises the prospect of cancer therapy that works by converting a tumor's best friends in the immune system into its gravest enemies.
Tags: BasicResearch, Immunotherapy
- Researchers link early prostate cancer to alterations in a program controlled by a "master regulator" of cell growth. This insight could open new avenues for preventing and treating prostate cancer.
Tags: BasicResearch, ProstateCancer
- Dana-Farber scientists and colleagues use genome- and epigenome-editing tools to pinpoint disease-causing variants.
Tags: BasicResearch, Genomics
Showing 1-10 of 152 items